Advertisement

Topics

Cynosure receives CFDA clearance for Icon aesthetic system in China

06:10 EST 1 Dec 2016 | Medical Business Review

Cynosure announced that it has received clearance from the China Food and Drug Administration (CFDA) to market the Icon aesthetic system, the Company's next-generation platform technology for multiple aesthetic indications.

Original Article: Cynosure receives CFDA clearance for Icon aesthetic system in China

NEXT ARTICLE

More From BioPortfolio on "Cynosure receives CFDA clearance for Icon aesthetic system in China"

Quick Search
Advertisement